Mabwell Achieves Milestone in TNBC Treatment with New Drug in US Trials Mabwell makes strides in cancer treatment with the first patient dosed in the US for its advanced therapy targeting TNBC. This landmark trial represents a significant step in addressing unmet medical needs.

Mabwell Achieves Milestone in TNBC Treatment with New Drug in US Trials #United_States #New_York #TNBC #Mabwell #Bulumtatug_Fuvedotin